This research service covers the U.S. alcohol dependence and abuse
pharmaceuticals market from 2003-2013. Included are patient forecasts and a
therapeutic overview. The market is segmented by product as follows: Antabuse,
Campral, ReVia, and Vivitrol. Major market challenges, drivers, restraints,
and strategic recommendations to overcome market challenges are also discussed.
Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules